BioTrinity 2026
14 April 2026 – 15 April 2026
Convene 133 Houndsditch, London, United Kingdom
BioTrinity 2026 was the 20th edition of OBN's flagship two-day conference for the life sciences industry. It brought together an international audience of around 850 delegates, including academic entrepreneurs, early-stage and emerging life sciences R&D companies, funders and investors, big pharma teams, charities, government and regulatory bodies, and professional service providers. The programme combined business and investment sessions, R&D company showcases streamed by funding stage, international market showcases and partnering meetings.
39 sessions · 223 speakers
Organiser (1)
Media Partners (8)
BioWales · FreeMind Group · Senglobalcoms · MedNous · Pharma Press Global · SEHTA · IBI · Zyme Communications
Sponsors (30)
Thermo Fisher · Curie.Bio · Porsolt · Marks & Clerk · Kadans Science Partner · Novotech (Australia) Pty Limited · PHARMExcel · Mills & Reeve · Biopharma Group · Carta · Bruntwood SciTech · Institute of Cancer Research · Castium Ltd · ARC - Advanced Research Clusters · University of Manchester Innovation Factory · RxCelerate · WuXi AppTec · The Oxford Science Park · Oxford North · Flanders Investment & Trade (FIT) · Nexus BioQuest · Medicilon · MEPC Milton Park · AWEX Wallonia · ERBC Group · Frazier & Deeter UK · Highlight People · Precision Health Technologies Accelerator Ltd (PHTA) · Wellcome Genome Campus · Syneos Health
Association Partners (9)
Medicon Valley Alliance · Japan Bioindustry Association · Life Sciences British Columbia · Life Science Austria Vienna - LISAvienna · Biocant Park · SwedenBIOE · Prague Bio · Asebio · Life Science Nord
Speakers (223)
- Kerstin Papenfuss CEO, Big Picture Bio
- Andrew Barron Global Clinical Operations Innovation & Transformation, Syneos Health
- Benedict Cross Founder & CEO, Stick Therapeutics Limited
- Gray Kueberuwa Chief Executive Officer, ImmunoKey
- Francesca Cordeiro St Marys Hospital NHS Trust
- Nick Watson Managing Director, OCO Global
- Catherine Bacon Founder & Chief Executive Officer, FINGERPOST
- Helen Philippou ClotProtect Therapeutics Limited
- Dr Uday Phadke Chief Executive & Founder, Triple Chasm Company
- Jenny Laird VP, Business Development - Neuroscience, Eli Lilly and Company
- Aline Charpentier Science Strategy & Innovation Lead, Wellcome Genome Campus
- Maria Koufali Life Sciences Industry Director, NIHR
- Sarah Leonard CEO, T-Cypher Bio Ltd
- Aleck Jones CEO and Co-Founder, Kindling Bio
- Jonathan Bracey Founder, MVA Society
- Lennard Lee Oxford University, Jenner Institute, NDM, University of Oxford
- Mohammad El Hajj CEO and Director, Bright Biotech Limited
- Kiren Baines-Mortimore CEO & Co-Founder, Valaya bio
- Semra Kitchen Senior Director, Search & Evaluation, R&I, AstraZeneca
- Lawrence Tallon Chief Executive, MHRA
- Tim Haines Executive Partner, Abingworth
- Adrian Ibrahim Head of Business Development and Technology Transfer, Base Rx
- Agata Nyga CEO, Mechanome Bio
- Agnieszka Janeczek CEO, Renovos Biologics Limited
- Ahmet Berkyurek CEO, Cambridge Medixine Ltd.
- Alastair Monteith-Hodge FRSA FCIM Founder & CEO, PreQlinic Limited
- Alexandr Ponomarev Chief Technology Officer (CTO), Limenbio Inc
- Alexandra Huener Head of Entrepreneurship, Milner Therapeutics Institute
- Alistair Williamson Managing Director, Lucid Group
- Allart Stoop Director, Danu Therapeutics limited
- Amir Golbang Trade Commissioner, Canadian High Commission
- Ana Gomes Founder and CEO, mPixl Technologies Ltd
- Anaid Benitez Founder and CEO, STRATISAL
- Andre Badalyan Co-Founder, Vantage Biosciences
- Andrea Dimitracopoulos Co-Founder & COO, deepMirror
- Andrew Grace Founder/CEO, TCEB Limited
- Angel CJ Wang CSO, Selene AI Ltd
- Anjan Aralihalli President & Founder, Raya Therapeutic, Inc.
- Anna Luisa Schaffgotsch CEO, Impli
- Anna Williamson Executive Director, Corporate Business Development, Roche
- Anne Corbett Professor of Dementia Research / Director, University of Exeter / PROTECT Digital
- Anne Michel CEO, HERMIONE THERAPEUTICS
- Antonia Molloy Postdoctoral Researcher/ Entrepreneurial Lead, University of Nottingham
- Aritz Lasarte-Cia Technology Transfer Manager, Cima Universidad de Navarra
- Arkadiy Ivanov Chief Development Officer (CDO), Limenbio Inc
- Arne Smolders CEO & Founder, Academiclabs
- Barney Smeaton Director, Choose New Jersey
- Ben Nichols CEO, SELENTUS SCIENCE LTD
- Benjamien Moeyaert Co-founder | Platform lead, Tavira Therapeutics
- Benjamin Damien CEO, Sagitta Biotech
- Benjamin Housden Industry Partnership Manager, UK Human Functional Genomics Initiative
- Bob Roopra Chairman, AssayGen
- Brenda VanHorn Minister-Counselor for Commercial Affairs, US Department of Commerce
- Carl Daintree COO, QV Bioelectronics
- Carol Yang Associate Professor, University of Exeter
- Caroline Haegeman Co-Founder & COO, Athernal Bio
- Caroline Stanton Head of SME Partnerships, University of Manchester Knowledge Exchange
- Cedric Constant CEO, Cerhum
- Chandan Seth Nanda CEO Founder, ToxiProofAI
- Chris Crockford Founder, Your Heart Check Limited
- Chris Saunter CTO, Magnitude Biosciences Limited
- Christian Schubert Vice President and Global Head, AbbVie Ventures, Abbvie Ventures
- Christophe Chassagnole CSO, XTalos Ltd
- Claire Russell Associate Professor in Developmental and Translational Neurobiology, The Royal Veterinary College
- Cliff Holloway CEO, Crucible Therapeutics
- Craig Beall Associate Professor, University of Exeter
- Darren Andrews CEO, NanoFormiX
- Dave Madge Vice President, Research Services Division, WuXi AppTec
- David Browning CTO, Precision Health Technologies Accelerator Ltd (PHTA)
- David Cavalla Executive Chairman and Co-founder, Serenatisbio
- David Fairen Jimenez CSO and founder, Vector Bioscience Cambridge
- David Klug Founder/CEO, Panacea Diagnostics
- Dominic Furniss Professor of Plastic and Reconstructive Surgery, Department of Biochemistry - University of Oxford
- Dora Marcec Founder and CEO, Gynomics Ltd
- Edward Parkinson Co-founder, Dadeni Therapeutics
- Elliott Jennings Interim Head of Investment & Licensing (Life Sciences), University of Manchester Innovation Factory
- Emmanuel Nony Director R&D External Innovation Europe, Servier
- Emyr Lloyd-Evans Professor, Cardiff University
- Faith Howard Fellow/CEO NANOncolytics, The University of Sheffield
- Felix Ciceron Post doctoral researcher - project lead, University of Exeter
- Francesca Fox CEO, NEWAVX
- Francesca Rapino CEO, THERAtRAME SA
- Francis White CEO, Heart Biotech Holdings Ltd
- Gábor Várkonyi Director, NeuroVLC
- Gaelle Boulet Co-founder aMylla, Gateaux BV/aMylla
- Gil Beyen CEO, Montis Biosciences BV
- Gordon Saxty coCEO/CSO and founder, SMIN Therapeutics
- Graham Ball CSO, Intelligent OMICS
- Gregor Bordon Founder, Eldian Biomed
- Harry Lamble CEO, Fuse Diagnostics
- Harsha Kantamneni CEO, Hado Therapeutics Ltd
- Hazel Jones Chief Operating Officer, Ambrose Healthcare Ltd
- Helen Botterill Associate, Clinical Business Solutions, Precision for Medicine
- Hugo Tewson Chair, Digostics Ltd
- Jack Bannister Founder, Vitamab
- Jacob Bush Director, Chemical Biology, GSK-Crick Joint Venture
- Jacob Thompson CEO, ADDER-VAX LIMITED
- Jaking Tang Co-founder, NEOrgan
- James Gavin CEO, Evolution therapeutics
- James Malone CTO, Luvida Ltd
- James Stephenson Founder, Variomis
- Jascha Blobel CEO, Golden Gait Biotech
- Jasper Van Hoorick CEO, BIO INX BV
- Jennifer Schneider CEO, Centauri Therapeutics Limited
- Jeremy Hill CEO, Your Health Digital
- Jeroen Verheyen Co-Founder & CEO, Semarion Ltd
- Jim Allpress Associate Director, External Innovation, Eisai Europe
- Johannes Schaeferhoff CEO, ROPCA
- John McKinley CEO & Director, Imspex Diagnostics Ltd
- Jon Rees Chief Executive Officer & Co-Founder, MitoRx Therapeutics
- Jordan Graves COO, Elastin Biosciences
- Julian Dye Dr/CEO, Oxartis Limited
- Julian Howell CEO, PharmaKrysto Ltd
- Karen Sullivan CEO, Galytx Ltd
- Kathrin Ballesteros Katemann CEO, Neurolieve Biosciences Ltd.
- Katja Rybakova Founder CELLGEBRA, Royal College of Surgeons Ireland
- Kelvin Stott CEO & Cofounder, Amporin Pharmaceuticals AG
- Kenneth Baillie CEO, Multiscale Labs
- Kevin Maskell Founder, CEO & CSO, Bioarchitech
- Kieran O'Donovan COO & CTO, NovalGen
- Kipp Kreutzberg Vice President of Global Sales & Marketing, Syneos Health
- Kourosh Saeb-Parsy Founder & CEO, Avatrial Ltd
- Laura Koivusalo CEO and founder, StemSight
- Lea Sefer Partnerships Manager, Ellele Health
- Lee Atkins CFO, Tachmed
- Lee Larcombe CEO/co-founder, Isoform Oncology Ltd
- Lien Lybaert Chief Development Officer, myNEO Therapeutics
- Louise Bates Director of Business Engagement and Knowledge Exchange, Manchester University
- Magnus Nicolson CEO, Invizius Ltd
- Maria Giovanna Lizio WILD Imaging
- Marine L’Herrou Global Director, Empire State Development (New York State)
- Mark Beards CEO, Santero Therapeutics
- Mark Julian Associate Director, Bruntwood SciTech
- Martina Lubrano di Ricco Chief of Staff, DeepLife
- Matej Metkovic CEO and Founder, Wasteless Bio
- Matthew Beard External Innovation, Ipsen
- Michael Dalrymple Director, IDxSense
- Michael Hunter CEO, Promatix Biosciences Ltd
- Mohammad Arastoo Principle scientist, TauBioGenix
- Muenuef Korkmaz Director, International Project Development, Evans General Contractors
- Nam Chol Park Chief Business Officer, Oxford Vacmedix UK Ltd
- Nasir Rajpoot CEO, Histofy
- Natalia Barkalina Director of Scientific Strategy, Syneos Health
- Nataly Hastings CEO, Cellestial Health Ltd
- Ned Wakeman CEO, NanOptima Limited
- Nicola McCarthy Head of Research, Milner Therapeutics Institute
- Nishan Ramnarain Founder, Artemis Medical
- Ove Vincent Solesvik CEO, GreinDX AS
- Patrik Frei CEO, Venture Valuation
- Paul Ko Ferrigno CEO, éclateral
- Philip Beales CEO, Axovia Therapeutics
- Philip Simister Head of Science and Entrepreneur Advocate, OBN
- Reuben Dawkins Co-founder & CEO, Link Biologics
- Richard Hopkins Pre Clinical Advisor, New Platelet Company
- Richard Unwin Professor of Disease Proteomics, The University of Manchester
- Rocky Cranenburgh CEO, Bitrobius Genetics Ltd
- Rod Chalk CEO, ionSIGHT Ltd
- Ron Jortner Founder & CEO, Aspire Biosciences
- Roona Deb Patent Attorney, Marks & Clerk LLP
- Rory Ryan CEO, PentaBind
- Ryan Cawood CEO, Lab Thread
- Saar De Breij UK Representative, Empire State Development (New York State)
- Safwan Mohammad Lab Supervisor, Advanced Research Clusters
- Sam Windsor Chief Executive Officer, Ignota Labs Limited
- Sara Memarpour Hobbi PDRA and Entrepreneurial Lead, The University of Sheffield
- Sarah Cole Chief Executive Officer, ISCARNA
- Sarah Coy Responsible Exploitation and Translation Officer, EEBio Programme, Department of Engineering Science, University of Oxford
- Sarah Hassan PDRA, UK Human Functional Genomics Initiative - PPTM Cluster
- Semen Trygubenko Director, Dodrotu Limited
- Sian Farrell CEO, StimOxyGen Ltd
- Simon Bornschein CEO, Coding Bio
- Simon Collings Head of Medical, Oxford Product Design
- Simon Ruck Managing Director, Oxford North
- Simone Lucanto CTO, MiDx
- Sobia Hamid Founder, Infinicell Bio
- Sophie Payne Founder, Inflammara Therapeutics
- Stephanie Annett Senior Lecturer and Principle Investigator, RCSI
- Steve Swioklo CSO and co-founder, atelerix ltd
- Stuart Hannah CEO, Microplate Dx
- Stuart Wood CEO and co-founder, Nascent Therapeutics
- Talveen Purba Research Fellow, The University of Manchester
- Tania Kpognon Deputy Director - UK & Ireland, South Carolina Department of Commerce
- Tessa Ogle CEO, Aureum Diagnostics Limited
- Thomas Hafner CEO, Onya Therapeutics
- Thomas Tran CEO, Aceso Therapeutics
- Thomas Wells Director of Commercial Growth, Frazier & Deeter UK LLP
- Tobias Bergmiller Co-Founder, PhageLink Bio
- William Hicks Member / Co-chair, Life Sciences Practice, Mintz Levin
- Xize Niu CEO, Droplet Scientific Ltd
- Yizhou Yu CEO, Founder, Healthspan Biotics
- Yogesh Prasad Founder, CEO, Biosecure ID Limited
- Yvanne Enever CEO, PHARMExcel
- Zeno Albisser CEO, Hemispherian AS
- Aron Jaffe Head of Bleeding Edge, Curie.Bio
- Astrid Geeraerts Head of Investment, Flanders
- Bart Geers Investment Manager, KU Leuven Research & Development
- Bharat Chudasama Vice President, Head of Strategic Partnerships, Syneos Health
- Birant Osman Executive Director, Thermofisher Scientific
- Cathy Tralau-Stewart Executive Director, Milner Therapeutics Institute
- Deborah Spencer ARC West London Health & Tech Cluster Lead, ARC - Advanced Research Clusters
- Emilie Syed Principal, Zinc
- Ian Murchie Barclays Bank PLC
- Jennifer Halbleib SSF Site Head for the Partnering Transactions Group, Roche
- Karl Keegan Head of Research, Singer Capital Markets
- Kathy Potter Corporate Tax Partner, Penningtons Manches Cooper
- Malcolm Silander Co-founder, Precision BioSearch
- Marc Reichlin Trade Commissioner, Embassy of Switzerland in the UK
- Mark Milsted Founder, Performance Method
- Matteo Cornaglia CEO & Co-founder, Nagi Biosicence
- Mavis Dwaah Director - Leadership Solutions, BDO LLP
- Max Baumann Partner, Treehill Partners
- Michel Rivier Executive Director, Syneos Health
- Paul Eschmann Head of Investment Promotion, Basel Area Business & Innovation
- Sonja Lawrence Founder, The TAR Network
- Tammy Thomas-Brown Director of Procurement and Contracts, Advanced Research + Invention Agency
- Tanya Moore Investment Principal, Cancer Research Horizons
- Thomas Eaton CEO, Limula
- Zied Tayeb Founder and CEO, MyelinZ
- Hannah Amies CEO, Luvida
- Hendrik Runge Co-Founder & Chief Executive Officer, Cambridge Nucleomics
- Larisa Fedorova HR Director - London Hub, Ipsen
- Michael Barron COO, NeedleSmart
- Shelley Margetson Managing Partner, V-Bio Ventures
Agenda
- BioTrinity Welcome 14 April 2026 · Enterprise Two
- Keynote: An Update on the Life Science Investment Landscape 14 April 2026 · Enterprise Two
- Seed Stage R&D Presentations: Session 1, kindly hosted by Syneos 14 April 2026 · Interact Room
- Panel Discussion: How to Thrive in Turbulent Times 14 April 2026 · Enterprise Two
- Series A R&D Presentations: Session 1 kindly hosted by Ipsen 14 April 2026 · Synergy
- Northern Ecosystem Showcase 14 April 2026 · Engage Room
- Panel Discussion: Your Guide to Alternative Sources of Funding 14 April 2026 · Enterprise Two
- Series A R&D Presentations: Session 2, Kindly hosted by WuXi AppTec 14 April 2026 · Synergy
- Seed Stage R&D Presentations: Session 2, kindly hosted by ARC Group 14 April 2026 · Interact Room
- Keynote: Navigating the Current Regulatory Landscape 14 April 2026 · Enterprise Two
- Keynote: Capital availability in a Constrained Market 14 April 2026 · Enterprise Two
- Series A R&D Presentations: Session 3, kindly hosted by PharmEXCEL 14 April 2026 · Synergy
- Seed Stage R&D Presentations Session 3 14 April 2026 · Interact Room
- Wellcome Genome Campus Showcase: How are BioData Ventures shaping the future of life sciences? 14 April 2026 · Engage Room
- NIHR Industry Engagement and Delivery Strategy 14 April 2026 · Enterprise Two
- Pre-Seed & Academic Poster Presentations: Session 1 14 April 2026 · Interact Room
- Series A R&D Presentations: Session 4, kindly hosted by Frazier & Deeter 14 April 2026 · Synergy
- Panel Discussion: What Makes a Super-Team (& How to Build Your Own) 14 April 2026 · Enterprise Two
- Milner Therapeutics Institute Showcase 14 April 2026 · Engage Room
- Pre-Seed & Academic Poster Presentations: Session 2 14 April 2026 · Interact Room
- Series A R&D Presentations: Session 5, Kindly hosted by Syneos Health 14 April 2026 · Synergy
- Panel Discussion: Unlocking the Power of Collaboration 14 April 2026 · Enterprise Two
- A Guide to Valuation for licensing to Pharma 14 April 2026 · Enterprise Two
- Introduction: The Power of a Global Growth Mindset 15 April 2026 · Enterprise Two
- Global Expansion in biopharma: Navigating Complexity across the US, Europe, Japan & China 15 April 2026 · Enterprise Two
- Seed Stage R&D Presentations: Session 4, kindly hosted by Marks & Clerk 15 April 2026 · Interact Room
- Series A R&D Presentations: Session 6, Kindly hosted by ARC Group 15 April 2026 · Synergy
- Panel Discussion: Utilising the Support & Expertise of UK Partners as you Grow 15 April 2026 · Enterprise Two
- Big Pharma Showcase 15 April 2026 · Engage Room
- USA Showcase Presentations 15 April 2026 · Enterprise Two
- Seed Stage R&D Presentations: Session 5, kindly hosted by PHTA 15 April 2026 · Interact Room
- Series A R&D Presentations: Session 7, kindly hosted by EY 15 April 2026 · Synergy
- Swiss Showcase Panel Discussion 15 April 2026 · Enterprise Two
- Series B Presentations, kindly hosted by OPD 15 April 2026 · Engage Room
- Pre-Seed & Academic Poster Presentations: Session 3 15 April 2026 · Interact Room
- Series A R&D Presentations: Session 8, kindly hosted by Oxford North 15 April 2026 · Synergy
- Flanders Showcase Panel Discussion 15 April 2026 · Enterprise Two
- Pre-Seed & Academic Poster Presentations: Session 4 15 April 2026 · Interact Room
- Canada Showcase Presentations 15 April 2026 · Enterprise Two